secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vivos Therapeutics, Inc. (VVOS)
CIK:        0001716166
Form:       8-K
Filed at:   2025-05-23T23:59:59+00:00
Accession:  0001641172-25-012181
Event type: debt
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vivos Therapeutics enters $1.1M convertible note to fund pending SCN acquisition
--------------------------------------------------------------------------------

- $1.1M principal convertible note to V-Co Investors 2 LLC; net funding $1M after $100k fee.
- Zero interest unless default; default rate 15% p.a.; secured by equipment only on default.
- Converts automatically into equity of subsequent financing expected at SCN closing (target July 31, 2025).
- Proceeds to fund previously announced acquisition of The Sleep Center of Nevada.
- V-Co is affiliate of existing investor New Seneca Partners Inc.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225012181/0001641172-25-012181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716166/000164117225012181/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-012181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer